Recombinant Human PD-L2/CD273 protein (His Tag)
种属
Human
纯度
>90 %, SDS-PAGE
标签
His Tag
生物活性
未测试
验证数据展示
产品信息
纯度 | >90 %, SDS-PAGE |
内毒素 | <0.1 EU/μg protein, LAL method |
生物活性 | Not tested |
来源 | HEK293-derived Human PD-L2 protein Leu20-Pro219 (Accession# Q9BQ51-1) with a His tag at the C-terminus. |
基因ID | 80380 |
蛋白编号 | Q9BQ51-1 |
预测分子量 | 26.4 kDa |
SDS-PAGE | 34-50 kDa, reducing (R) conditions |
组分 | Lyophilized from 0.22 μm filtered solution in PBS, pH 7.4. Normally 5% trehalose and 5% mannitol are added as protectants before lyophilization. |
复溶 | Briefly centrifuge the tube before opening. Reconstitute at 0.1-0.5 mg/mL in sterile water. |
储存条件 |
It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
|
运输条件 | The product is shipped at ambient temperature. Upon receipt, store it immediately at the recommended temperature. |
背景信息
Programmed cell death ligand 2 (PD-L2, also known as CD273, or B7-DC), is one of the B7 family molecules which are type I transmembrane proteins belonging to the immunoglobulin superfamily. PD-L2 was identified both by its homology to PD-L1 and by analysis of genes differentially expressed in libraries generated from dendritic cells (DC) and activated macrophages. It consists of an extracellular region containing an IgV-like domain and an IgC-like domain, a transmembrane region, and a short cytoplasmic domain. PD-L2 is a second ligand for PD-1, a costimulatory molecule that plays an inhibitory role in regulating T-cell activation.
参考文献:
1.S Y Tseng, et al. (2001) J Exp Med. 193(7):839-46. 2.Y Latchman, et al. (2001) Nat Immunol. 2(3):261-8. 3.Spencer C Liang, et al. (2003) Eur J Immunol. 33(10):2706-16.